FORBES 30 under 30 Europe
Dr. Mattias Ivarsson, Cofounder of Inositec AG and former member of Prof. Leroux's Drug Formulation & Delivery research group, is listed in FORBES as one of the 30 under 30 persons with his non-antibiotic drug candidates that don't promote drug-resistant strains.
by
Monica Langfritz-Gütermann
With is ETH spinn-off company external page Inositec, Dr. Mattias Ivarsson has made it into external page Forbes 30 UNDER 30 list in the category of Science & Healthcare.